Smartphone application for women with gestational diabetes

Assessing the effect of education based-on smartphone application on risk perception of type 2 diabetes and self-efficacy among women with gestational diabetes: A Controlled clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201705092769N4

Enrollment

Registered

2017-07-06

Start date

2017-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational Diabetes. Diabetes mellitus arising in pregnancy

Interventions

Intervention 1: Intervention group: Educational smartphone applications will be available to patients in the intervention group and they will be asked to use applications for 6 weeks. The option of re

Prevention

Intervention group: Educational smartphone applications will be available to patients in the intervention group and they will be asked to use applications for 6 weeks. The option of reminding use of p

The control group will receive routine hospital ward education.

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Gestational diabetes diagnosis has been recorded in the patient file bearing approval of physician; Is under treatment with insulin; Having age of 18 to 40 years; Pregnancy age of 22 to 32 weeks; Having singleton pregnancy; Having spontaneous pregnancy without use of assisted reproductive techniques; No history of gestational diabetes mellitus; Having literary for reading and writing; Having smart phone with Android operating system; Having ability of working with applications of mobile phone (to startup the program at the presence of researcher). exclusion criteria: Lack of desire to continue to participate in the study; Multiple pregnancy;Having delivery during intervention; History of gestational diabetes mellitus; Having diabetes before pregnancy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Risk Perception of type 2 diabetes. Timepoint: Baseline, 6weeks after intervention. Method of measurement: Risk Perception Survey Developing- Diabetes.;Self-Efficacy. Timepoint: Baseline, 6weeks after intervention. Method of measurement: Diabetic Self-Efficacy Scale.	—

Secondary

Measure	Time frame
-. Timepoint: -. Method of measurement: -.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMansoureh Ashghali Farahani

School of Nursing and Midwifery, Iran Universityof Medical Science

m_negar@yahoo.com? Farahani.ma@iums.ac.ir+98 21 8888 2885

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026